Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03002688
Other study ID # 2016H0032
Secondary ID
Status Completed
Phase
First received December 15, 2016
Last updated April 10, 2018
Start date January 2017
Est. completion date March 2018

Study information

Verified date April 2018
Source Ohio State University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose is to gauge the patients' level of comfort and anxiety for sequential cataract surgeries to assess if the second experience of cataract surgery differs from the initial experience.


Description:

Each patient is scheduled to undergo two sequential cataract extractions under topical anesthesia with local anesthetic eye drops and minimal sedation- one on each eye. The surgeon, basic surgical procedure, anesthetic technique, and approximate length of procedure are reasonably similar and the patients act as their own control. Subjects in the study will answer very brief questions regarding anxiety and comfort about their surgery before and after each procedure, and on the day after their second surgery.


Recruitment information / eligibility

Status Completed
Enrollment 286
Est. completion date March 2018
Est. primary completion date March 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Patients undergoing sequential cataract surgeries within a 6 week time period performed by the ophthalmologist, Amit Tandon, MD.

2. Aged 18 years and older.

Exclusion Criteria:

1. Cognitive impairment causing inability to participate in survey

2. Language barrier causing an inability to participate in survey

3. Healthcare POA or guardian leading to an inability to consent to survey

4. Physician autonomy; patients that are inappropriate for the study as deemed by investigator

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Survey
Verbal survey will be given before and after the cataract surgery, and on the day following the second cataract surgery.

Locations

Country Name City State
United States The Ohio State University Wexner Medical Center Columbus Ohio

Sponsors (1)

Lead Sponsor Collaborator
Ohio State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Pain will be evaluated using verbal survey after each cataract surgery, scheduled to occur within 6 weeks time; subject will be asked if there was any difference in pain between surgeries on the day after the second cataract surgery. First and second cataract extraction surgery occuring within 6 weeks
Primary Anxiety Anxiety will be evaluated using verbal survey before each cataract surgeries, scheduled to occur within 6 weeks time; subject will be asked if there was any difference in anxiety between surgeries on the day after the second cataract surgery. First and second cataract extraction surgery occuring within 6 weeks
Primary Awareness Awareness will be evaluated using verbal survey after each cataract surgeries, scheduled to occur within 6 weeks time; subject will be asked if there was any difference in awareness between surgeries on the day after the second cataract surgery. First and second cataract extraction surgery occuring within 6 weeks
Primary Comfort Level Comfort level will be evaluated using verbal survey after cataract surgeries, scheduled to occur within 6 weeks time; subject will be asked if there was any difference in comfort level between surgeries on the day after the second cataract surgery. First and second cataract extraction surgery occuring within 6 weeks